This Article Full Text Full Text (PDF) All Versions of this Article: 112/5/691    most recent CIRCULATIONAHA.104.503938v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grandel, U. Articles by Sibelius, U. Search for Related Content PubMed PubMed Citation Articles by Grandel, U. Articles by Sibelius, U. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Contractile function Other heart failure Animal models of human disease Physiological and pathological control of gene expression Other Vascular biology

(Circulation. 2005;112:691-698.)
© 2005 American Heart Association, Inc.

Heart Failure

Mechanisms of Cardiac Depression Caused by Lipoteichoic Acids From Staphylococcus aureus in Isolated Rat Hearts

Ulrich Grandel, MD; Michael Hopf, MD; Michael Buerke, MD; Katja Hattar, MD; Martina Heep; Ludger Fink, MD; Rainer M. Bohle, MD; Siegfried Morath, PhD; Thomas Hartung, MD, PhD; Soni Pullamsetti; Ralph T. Schermuly, PhD; Werner Seeger, MD; Friedrich Grimminger, MD, PhD; Ulf Sibelius, MD

From the Departments of Internal Medicine (U.G., M. Hopf, K.H., M. Heep, S.P., R.T.S., W.S., F.G., U.S.) and Pathology (L.F., R.M.B.), Justus Liebig University, Giessen; Department of Internal Medicine, Martin Luther University, Halle-Wittenberg (M.B.); and Department of Biochemical Pharmacology, University of Konstanz, Konstanz (S.M., T.H.), Germany.

Correspondence to Ulf Sibelius, MD, Department of Internal Medicine, Klinikstrasse 36, D-35392 Giessen, Germany. E-mail ulf.sibelius{at}innere.med.uni-giessen.de

Received September 13, 2004; revision received April 19, 2005; accepted April 22, 2005.

Background— Lipoteichoic acid (LTA) represents a major virulence factor in gram-positive sepsis.

Methods and Results— In the present study we perfused isolated rat hearts for 180 minutes with highly purified LTA from Staphylococcus aureus. A progressive decline of left ventricular contractile function paralleled by the expression of myocardial tumor necrosis factor- (TNF-) mRNA and protein as well as the release of TNF- into the perfusate was observed in LTA-perfused hearts. Employment of an anti–TNF- antibody completely prevented the loss in contractile function. When CD14, a prominent pathogen recognition receptor, was blocked by a specific antibody, induction of TNF- mRNA and protein release as well as the associated cardiodepression was diminished in response to LTA. Synthesis of TNF- protein was located to interstitial cells of LTA-challenged hearts as detected by immunohistochemistry. Besides progressive cardiodepression, coronary perfusion pressure (CPP) was moderately increased in LTA-perfused hearts. This was accompanied by the release of thromboxane A₂ (TXA₂) into the perfusate and the induction of cyclooxygenase (Cox)-2 mRNA and protein in the myocardium. Blocking of TXA₂ by the nonspecific Cox inhibitor indomethacin, the thromboxane receptor antagonist daltroban, or the selective Cox-2 inhibitor NS-398 prevented the increase in CPP.

Conclusions— LTA causes cardiac depression by activating myocardial TNF- synthesis via CD14 and induces coronary vascular disturbances by activating Cox-2–dependent TXA₂ synthesis. These phenomena may contribute to cardiac depression in gram-positive sepsis.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				M.W. Merx and C. Weber Sepsis and the Heart Circulation, August 14, 2007; 116(7): 793 - 802. [Abstract] [Full Text] [PDF]